medigraphic.com
ISSN 2007-3178 (Print)
Asociación Mexicana de Cirugía Bucal y Maxilofacial, Colegio Mexicano de Cirugía Bucal y Maxilofacial, A.C.

2020, Number 1

<< Back Next >>

Rev Mex Cir Bucal Maxilofac 2020; 16 (1)

Rhinocerebral mucormycosis: a case report and literature review

Julián CA, Crespo RPA

Language: Spanish
References: 15
Page: 22-26
PDF size: 355.84 Kb.


ABSTRACT

Mucormycosis is a fungal infection produced by the order of mucorales of the zygomycete family, mainly affects immunocompromised individuals, has a high mortality and morbidity rate, early treatment of the underlying pathology and infection are key to a successful this treatment. We present the case of a 17-year-old female patient who presents with a picture of diabetic ketoacidosis and rhinocerebral mucormycosis, describing the surgical medical treatment that was carried out.


REFERENCES

  1. Metzen D, Böhm H, Zimmermann M, Reuther T, Kübler AC, Müller-Richter, UDA. Mucormycosis of the head and neck. J Craniomaxillofac Surg. 2012; 40 (8): e321-e327.

  2. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012; 54 (Suppl 1): S23-S34.

  3. Camara-Lemarroy CR, González-Moreno EI, Rodríguez-Gutiérrez R, Rendón-Ramírez EJ, Ayala-Cortés AS, Fraga-Hernández ML, Galarza-Delgado DA. Clinical features and outcome of mucormycosis. Interdiscip Perspect Infect Dis. 2014; 2014: 562610.

  4. Jeong W, Keighley C, Wolfe R, Lee WL, Slavin MA, Kong DC, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clinical Microbiology and Infection. 2018, 25 (1): 26-34.

  5. Swain SK, Sahu MC, Banerjee A. Non-sinonasal isolated facio-orbital mucormycosis. A case report. J Mycol Med. 2018; 28 (3): 538-541.

  6. Kudo K, Hasegawa H, Sato E, Kaneko T, Ishida D, Kanno C, Endo M. A case of rhinocerebral mucormycosis extending into the skull. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2017; 29(1): 61-64.

  7. Baldin C, Ibrahim AS. Molecular mechanisms of mucormycosis: the bitter and the sweet. PLoS Pathog. 2017; 13 (8). e1006408.

  8. Acosta BC, Lucio LE, Uribe CA, Gómez MB. Mucormicosis rinocerebral de origen dental, reporte de un caso clínico y revisión de la literatura. Rev Esp Cirug Oral y Maxilofac. 2014; 36 (2): 68-72.

  9. Farmakiotis D, Kontoyiannis DP. Mucormycoses. Infect Dis Clin North Am. 2016; 30 (1): 143-163.

  10. Therakathu J, Prabhu S, Irodi A, Sudhakar SV, Yadav VK, Rupa V. Imaging features of rhinocerebral mucormycosis: A study of 43 patients. The Egyptian Journal of Radiology and Nuclear Medicine. 2018; 49 (2): 447-452.

  11. Elzein F, Kalam K, Mohammed N, Elzein A, Alotaibi FZ, Khan M, Albadani A. Treatment of cerebral mucormycosis with drug therapy alone: a case report. Med Mycol Case Rep. 2019; 23: 4-7.

  12. Gebremariam T, Liu M, Luo G, Bruno V, Phan QT, Waring AJ et al. CotH3 mediates fungal invasion of host cells during mucormycosis. J Clin Invest. 2014; 124 (1): 237-250.

  13. Kim J, Forston JK, Cook HE. A fatal outcome from rhinocerebral mucormycosis after dental extractions: a case report. J Oral Maxillofac Surg. 2001; 59: 693-697.

  14. Pandey A, Bansal V, Asthana AK, Trivedi V, Madan M, Das A. Maxillary osteomyelitis by mucormycosis: report of four cases. Int J Infect Dis. 2011; 15 (1): e66-e69.

  15. Malik AN, Bi WL, McCray B, Abedalthagafi M, Vaitkevicius H, Dunn IF. Isolated cerebral mucormycosis of the basal ganglia. Clin Neurol Neurosurg. 2014; 124: 102-105.




2020     |     www.medigraphic.com